HilleVax (HLVX) Competitors $2.09 -0.01 (-0.48%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$2.06 -0.03 (-1.48%) As of 07/11/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HLVX vs. RZLT, PRME, ERAS, TECX, SLDB, ITOS, ETON, ALT, CMPX, and CYRXShould you be buying HilleVax stock or one of its competitors? The main competitors of HilleVax include Rezolute (RZLT), Prime Medicine (PRME), Erasca (ERAS), Tectonic Therapeutic (TECX), Solid Biosciences (SLDB), iTeos Therapeutics (ITOS), Eton Pharmaceuticals (ETON), Altimmune (ALT), Compass Therapeutics (CMPX), and CryoPort (CYRX). These companies are all part of the "pharmaceutical products" industry. HilleVax vs. Its Competitors Rezolute Prime Medicine Erasca Tectonic Therapeutic Solid Biosciences iTeos Therapeutics Eton Pharmaceuticals Altimmune Compass Therapeutics CryoPort Rezolute (NASDAQ:RZLT) and HilleVax (NASDAQ:HLVX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations. Do analysts recommend RZLT or HLVX? Rezolute currently has a consensus price target of $11.83, suggesting a potential upside of 124.97%. HilleVax has a consensus price target of $2.00, suggesting a potential downside of 4.31%. Given Rezolute's stronger consensus rating and higher probable upside, equities research analysts clearly believe Rezolute is more favorable than HilleVax.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rezolute 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14HilleVax 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has better valuation & earnings, RZLT or HLVX? Rezolute is trading at a lower price-to-earnings ratio than HilleVax, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRezoluteN/AN/A-$68.46M-$1.15-4.57HilleVaxN/AN/A-$147.27M-$2.15-0.97 Is RZLT or HLVX more profitable? HilleVax's return on equity of -51.86% beat Rezolute's return on equity.Company Net Margins Return on Equity Return on Assets RezoluteN/A -70.09% -63.08% HilleVax N/A -51.86%-41.45% Do institutionals and insiders have more ownership in RZLT or HLVX? 83.0% of Rezolute shares are owned by institutional investors. Comparatively, 86.4% of HilleVax shares are owned by institutional investors. 18.4% of Rezolute shares are owned by company insiders. Comparatively, 24.9% of HilleVax shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to RZLT or HLVX? In the previous week, Rezolute had 2 more articles in the media than HilleVax. MarketBeat recorded 5 mentions for Rezolute and 3 mentions for HilleVax. HilleVax's average media sentiment score of 1.46 beat Rezolute's score of 0.72 indicating that HilleVax is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rezolute 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HilleVax 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, RZLT or HLVX? Rezolute has a beta of 1.03, indicating that its stock price is 3% more volatile than the S&P 500. Comparatively, HilleVax has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500. SummaryRezolute beats HilleVax on 8 of the 14 factors compared between the two stocks. Get HilleVax News Delivered to You Automatically Sign up to receive the latest news and ratings for HLVX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HLVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HLVX vs. The Competition Export to ExcelMetricHilleVaxMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$105.30M$2.97B$5.62B$9.10BDividend YieldN/A2.39%5.24%4.00%P/E Ratio-0.9720.5828.0520.27Price / SalesN/A292.05429.5999.27Price / CashN/A42.8637.4658.16Price / Book0.677.638.055.49Net Income-$147.27M-$55.05M$3.18B$250.45M7 Day Performance1.70%8.43%3.60%4.77%1 Month Performance8.85%5.42%4.03%7.66%1 Year Performance19.43%2.03%29.49%16.39% HilleVax Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HLVXHilleVax2.1123 of 5 stars$2.09-0.5%$2.00-4.3%+25.1%$105.30MN/A-0.9720News CoveragePositive NewsRZLTRezolute2.5905 of 5 stars$4.98+3.3%$11.83+137.6%+22.9%$412.20MN/A-4.3340News CoverageHigh Trading VolumePRMEPrime Medicine3.9289 of 5 stars$3.80+22.2%$10.08+165.4%-27.5%$408.32M$3.85M-1.85234Positive NewsHigh Trading VolumeERASErasca3.2141 of 5 stars$1.42-1.4%$4.57+221.9%-48.4%$407.93MN/A-2.29120News CoverageTECXTectonic Therapeutic2.6203 of 5 stars$20.78-2.6%$83.60+302.3%+37.7%$398.47MN/A-2.84120Gap DownSLDBSolid Biosciences3.1534 of 5 stars$4.91-2.4%$15.10+207.5%-35.8%$389.90M$8.09M-1.64100News CoverageGap DownITOSiTeos Therapeutics3.3166 of 5 stars$10.07-1.1%$15.86+57.5%-36.5%$389.63M$35M-3.3190ETONEton Pharmaceuticals1.9777 of 5 stars$14.39-0.4%$29.67+106.2%+322.4%$387.51M$39.01M-79.9420ALTAltimmune2.2384 of 5 stars$4.43-6.9%$19.00+328.9%-46.1%$386.07M$20K-3.5250News CoverageAnalyst ForecastGap DownCMPXCompass Therapeutics3.0139 of 5 stars$2.64-5.0%$12.67+379.8%+159.6%$384.43M$850K-6.4420News CoveragePositive NewsCYRXCryoPort1.8271 of 5 stars$7.29-4.8%$10.88+49.2%+7.4%$384.05M$228.38M-3.121,186 Related Companies and Tools Related Companies RZLT Competitors PRME Competitors ERAS Competitors TECX Competitors SLDB Competitors ITOS Competitors ETON Competitors ALT Competitors CMPX Competitors CYRX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HLVX) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HilleVax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HilleVax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.